Director

Craig B. Thompson

Director (President Emeritus and Former President and Chief Executive Officer, Memorial Sloan Kettering Cancer Center)·Charles River Laboratories International, Inc.

About

C

r

a

i

g

B

.

T

h

o

m

p

s

o

n

,

M

.

D

.

,

i

s

t

h

e

f

o

r

m

e

r

P

r

e

s

i

d

e

n

t

a

n

d

C

h

i

e

f

E

x

e

c

u

t

i

v

e

O

f

f

i

c

e

r

o

f

M

e

m

o

r

i

a

l

S

l

o

a

n

-

K

e

t

t

e

r

i

n

g

C

a

n

c

e

r

C

e

n

t

e

r

,

a

p

o

s

i

t

i

o

n

h

e

h

e

l

d

f

r

o

m

2

0

1

0

t

o

S

e

p

t

e

m

b

e

r

2

0

2

2

.

D

r

.

T

h

o

m

p

s

o

n

c

o

n

t

i

n

u

e

s

t

o

o

v

e

r

s

e

e

a

r

e

s

e

a

r

c

h

l

a

b

o

r

a

t

o

r

y

a

t

t

h

e

S

l

o

a

n

K

e

t

t

e

r

i

n

g

I

n

s

t

i

t

u

t

e

f

o

c

u

s

i

n

g

o

n

c

e

l

l

u

l

a

r

m

e

t

a

b

o

l

i

s

m

a

n

d

i

t

s

r

o

l

e

i

n

c

a

n

c

e

r

.

F

r

o

m

2

0

0

6

t

o

2

0

1

0

,

h

e

s

e

r

v

e

d

a

s

D

i

r

e

c

t

o

r

o

f

t

h

e

A

b

r

a

m

s

o

n

C

a

n

c

e

r

C

e

n

t

e

r

a

t

t

h

e

U

n

i

v

e

r

s

i

t

y

o

f

P

e

n

n

s

y

l

v

a

n

i

a

S

c

h

o

o

l

o

f

M

e

d

i

c

i

n

e

,

a

n

d

f

r

o

m

1

9

9

9

t

o

2

0

1

1

h

e

w

a

s

a

P

r

o

f

e

s

s

o

r

o

f

M

e

d

i

c

i

n

e

a

n

d

C

a

n

c

e

r

B

i

o

l

o

g

y

a

t

t

h

e

U

n

i

v

e

r

s

i

t

y

o

f

P

e

n

n

s

y

l

v

a

n

i

a

.

D

r

.

T

h

o

m

p

s

o

n

i

s

c

u

r

r

e

n

t

l

y

a

m

e

m

b

e

r

o

f

t

h

e

B

o

a

r

d

o

f

D

i

r

e

c

t

o

r

s

o

f

R

e

g

e

n

e

r

o

n

P

h

a

r

m

a

c

e

u

t

i

c

a

l

s

,

I

n

c

.

,

a

n

d

p

r

e

v

i

o

u

s

l

y

s

e

r

v

e

d

o

n

t

h

e

B

o

a

r

d

o

f

D

i

r

e

c

t

o

r

s

o

f

M

e

r

c

k

&

C

o

.

I

n

c

.

f

r

o

m

2

0

0

9

t

o

2

0

1

8

.

H

e

i

s

a

l

s

o

a

b

o

a

r

d

m

e

m

b

e

r

o

f

t

h

e

H

o

w

a

r

d

H

u

g

h

e

s

M

e

d

i

c

a

l

I

n

s

t

i

t

u

t

e

,

M

.

D

.

A

n

d

e

r

s

o

n

C

a

n

c

e

r

C

e

n

t

e

r

,

O

h

i

o

S

t

a

t

e

U

n

i

v

e

r

s

i

t

y

C

o

m

p

r

e

h

e

n

s

i

v

e

C

a

n

c

e

r

C

e

n

t

e

r

,

a

n

d

a

m

e

m

b

e

r

o

f

t

h

e

A

l

b

e

r

t

L

a

s

k

e

r

M

e

d

i

c

a

l

R

e

s

e

a

r

c

h

A

w

a

r

d

s

P

r

i

z

e

C

o

m

m

i

t

t

e

e

.

H

e

i

s

a

n

e

l

e

c

t

e

d

m

e

m

b

e

r

o

f

t

h

e

N

a

t

i

o

n

a

l

A

c

a

d

e

m

y

o

f

S

c

i

e

n

c

e

s

,

t

h

e

N

a

t

i

o

n

a

l

A

c

a

d

e

m

y

o

f

M

e

d

i

c

i

n

e

,

t

h

e

A

m

e

r

i

c

a

n

A

c

a

d

e

m

y

o

f

A

r

t

s

a

n

d

S

c

i

e

n

c

e

s

,

a

n

d

t

h

e

A

s

s

o

c

i

a

t

i

o

n

o

f

A

m

e

r

i

c

a

n

P

h

y

s

i

c

i

a

n

s

.

D

r

.

T

h

o

m

p

s

o

n

h

o

l

d

s

a

n

u

m

b

e

r

o

f

p

a

t

e

n

t

s

r

e

l

a

t

e

d

t

o

i

m

m

u

n

o

t

h

e

r

a

p

y

a

n

d

a

p

o

p

t

o

s

i

s

a

n

d

h

a

s

f

o

u

n

d

e

d

t

h

r

e

e

b

i

o

t

e

c

h

n

o

l

o

g

y

c

o

m

p

a

n

i

e

s

,

i

n

c

l

u

d

i

n

g

A

g

i

o

s

P

h

a

r

m

a

c

e

u

t

i

c

a

l

s

.

D

r

.

T

h

o

m

p

s

o

n

h

a

s

b

e

e

n

a

d

i

r

e

c

t

o

r

o

f

C

h

a

r

l

e

s

R

i

v

e

r

s

i

n

c

e

D

e

c

e

m

b

e

r

2

0

2

2

.

H

e

w

a

s

s

e

l

e

c

t

e

d

t

o

t

h

e

B

o

a

r

d

i

n

r

e

c

o

g

n

i

t

i

o

n

o

f

h

i

s

p

e

r

s

p

e

c

t

i

v

e

a

s

a

h

i

g

h

l

y

d

i

s

t

i

n

g

u

i

s

h

e

d

a

c

a

d

e

m

i

c

a

n

d

e

d

u

c

a

t

o

r

i

n

m

e

d

i

c

i

n

e

a

n

d

h

i

s

e

x

t

e

n

s

i

v

e

s

c

i

e

n

t

i

f

i

c

a

n

d

m

e

d

i

c

a

l

e

x

p

e

r

t

i

s

e

r

e

l

e

v

a

n

t

t

o

l

i

f

e

s

c

i

e

n

c

e

i

n

d

u

s

t

r

i

e

s

,

i

n

c

l

u

d

i

n

g

t

h

e

r

e

s

e

a

r

c

h

a

n

d

d

e

v

e

l

o

p

m

e

n

t

a

c

t

i

v

i

t

i

e

s

o

f

t

h

e

C

o

m

p

a

n

y

'

s

c

l

i

e

n

t

s

.

Since December 2022
Age 73
Tenure 4 yrs

Also at Charles River Laboratories International, Inc.

JF James C. Foster Chair, President and Chief Executive Officer BG Birgit Girshick Corporate Executive Vice President and Chief Operating Officer (Chief Executive Officer effective May 5, 2026) NA Nancy C. Andrews Director (Executive Vice President and Chief Scientific Officer, Boston Children's Hospital) SB Steven Barg Director (Global Co-Head of Engagement, Elliott Investment Management L.P.) AC Abraham Ceesay Director (Chief Executive Officer, Rapport Therapeutics) ME Mark Enyedy Director (Former President and Chief Executive Officer, ImmunoGen, Inc.)

Roles

Organization Role Dates Details
Charles River Laboratories International, Inc. Director (President Emeritus and Former President and Chief Executive Officer, Memorial Sloan Kettering Cancer Center) December 2022–present Current role
Memorial Sloan-Kettering Cancer Center President and Chief Executive Officer 2010 - Sep 2022 Continues to oversee a research laboratory at the Sloan Kettering Institute focusing on cellular metabolism and its role in cancer.
University of Pennsylvania School of Medicine Director of the Abramson Cancer Center 2006 - 2010
University of Pennsylvania Professor of Medicine and Cancer Biology 1999 - 2011
Memorial Sloan Kettering Cancer Center President and Chief Executive Officer 2010-2022

External roles

Organization Role Dates
Regeneron Pharmaceuticals, Inc. Director present
Merck & Co. Inc. Director 2009 - 2018
Howard Hughes Medical Institute Board member
M.D. Anderson Cancer Center Board member
Ohio State University Comprehensive Cancer Center Board member
Albert Lasker Medical Research Awards Prize Committee Member
Regeneron Pharmaceuticals Director 2022-present

Related

Company Charles River Laboratories International, Inc. Company hub Person James C. Foster Chair, President and Chief Executive Officer Person Birgit Girshick Corporate Executive Vice President and Chief Operating Officer (Chief Executive Officer effective May 5, 2026) Person Nancy C. Andrews Director (Executive Vice President and Chief Scientific Officer, Boston Children's Hospital) Person Steven Barg Director (Global Co-Head of Engagement, Elliott Investment Management L.P.) Person Abraham Ceesay Director (Chief Executive Officer, Rapport Therapeutics) Person Mark Enyedy Director (Former President and Chief Executive Officer, ImmunoGen, Inc.) Person Paul Graves Director (Former Chief Executive Officer, Rio Tinto Lithium) Person Reshema Kemps-Polanco Director (Executive Vice President and Chief Commercial Officer, Novartis US) Person George Llado, Sr. Director (Former Senior Vice President and Chief Information Officer, Alexion Pharmaceuticals, Inc.) Person Martin W. Mackay Director (Lead Independent Director; Co-Founder and Non-Executive Chair, Rallybio Corporation) Person Virginia M. Wilson Director (Retired Senior Executive Vice President and Chief Financial Officer, TIAA) Person Michael Knell Interim Chief Financial Officer, Corporate Senior Vice President, and Chief Accounting Officer Deal Charles River Laboratories International Agilux Laboratories 2016 Deal page Deal Charles River Laboratories International Argenta And Biofocus Cro Services Division Of Galapagos 2014 Deal page Deal Charles River Laboratories International Blue Stream Laboratories 2016 Deal page
Source: Charles River Laboratories International, Inc. SEC filings and official company website

See how VectorShift works for your firm

Request Demo